Pharmdca(@Pharmdca) 's Twitter Profileg
Pharmdca

@Pharmdca

USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of where Iam investing money and not a recommendation. Please do your due diligence.

ID:1884013189

calendar_today19-09-2013 18:28:05

86,1K Tweets

90,3K Followers

141 Following

Data Driven Investing(@DataDInvesting) 's Twitter Profile Photo

This is pretty incredible. Forbes just ranked $SOFI as the 5th best bank in the United States. They only became a bank two years ago. That's some excellent progress.

account_circle
Pharmdca(@Pharmdca) 's Twitter Profile Photo

$NARI Inari Medical to Announce First Quarter 2024 Financial Results on April 30th

$LLY earnings on April 30th

$DAWN $XFOR FDA decision April 30th

Long all

account_circle
TradeTheNews.com(@Trade_The_News) 's Twitter Profile Photo

$MELI Plans to increase headcount by 30% in 2024 by hiring ~18K people; Seeks to build its business in Mexico and elsewhere - press (MercadoLibre Inc)
(More at tradethenews.com/?twtId=47384)

account_circle
Pharmdca(@Pharmdca) 's Twitter Profile Photo

$UNH $HUM $CVS Beaten down health insurance companies rebound continues after $UNH updated earnings yesterday

account_circle
Pharmdca(@Pharmdca) 's Twitter Profile Photo

$LLY Shares up 2.3%

Eli Lillys drug Zepbound significantly reduced the severity of sleep apnea in patients in a new study, while also helping them lose weight.

$VKTX $NVO

Long $VKTX $LLY

account_circle
Pharmdca(@Pharmdca) 's Twitter Profile Photo

$VKTX $LLY $NVO

STATINS and ERECTILE DYSFUNCTION are too indications that come to my mind where the first ones to the market does not necessarily means the biggest revenue generator over time.

Both STATINS and ED- Irrespective of when drugs were approved, most did well over…

account_circle
Pharmdca(@Pharmdca) 's Twitter Profile Photo

$VKTX Obesity is just that huge market that few players won't be able to meet the needs over time.
If we learn something important from STATINS blockbuster drugs it was that multiple players irrespective of when they entered the market after FDA approval, most generated…

account_circle
Pharmdca(@Pharmdca) 's Twitter Profile Photo

$VKTX Good pullback in shares after hitting almost $100 offers good opportunity. This is one of my top convictions in biospace. Company already reported better than expected efficacy and safety for both SubQ and Oral drugs.

Upcoming earnings from $LLY should show continued…

account_circle
Katusa Research(@KatusaResearch) 's Twitter Profile Photo

Canada just upped capital gains from 50% to 67%.

Canadian equities are already hurting for volume and momentum.

Could be a lot of profit taking coming before the June 25 deadline.

account_circle